Principles of allergic rhinitis treatment
https://doi.org/10.21518/2079-701X-2013-7-42-47
Abstract
According to WHO estimates, in the XXI century allergy will be the second most widespread disorder, giving way only to mental illnesses. There is a marked aggravation of allergies and polysensitization; immunological disorders are accompanied by comorbid infectious complications. Allergic rhinitis is a global healthcare problem. The focus of the international medical community is explained by a range of medical and social reasons. Treatment of allergic rhinitis requires a comprehensive approach taking into account the pathogenesis of the disease.
About the Authors
A. I. Kryukov
Moscow Otorhinolaryngology Research and Practical Centre named after L.I. Sverzhevskiy, Moscow Healthcare Department
Russian Federation
Russian Federation
A. B. Turovskiy
Moscow Otorhinolaryngology Research and Practical Centre named after L.I. Sverzhevskiy, Moscow Healthcare Department
Russian Federation
Russian Federation
G. P. Bondareva
Moscow Otorhinolaryngology Research and Practical Centre named after L.I. Sverzhevskiy, Moscow Healthcare Department
Russian Federation
Russian Federation
O. V. Semkina
Moscow Otorhinolaryngology Research and Practical Centre named after L.I. Sverzhevskiy, Moscow Healthcare Department
Russian Federation
Russian Federation
References
1. Арефьева Н.А. Иммунология, иммунопатология и проблемы иммунотерапии. Уфа: БГМУ, 1997. 120 с.
2. Гаджимирзаев Г.А., Гамзатова А.А., Гаджимирзаева Р.Г. Аллергические риниты у детей и взрослых. Махачкала, 2002. 311 с.
3. Косарев В.В., Жестков А.В., Зайцева С.А., Еремина Н.В. Эпидемиология, клинико-иммунологические аспекты аллергических заболеваний респираторного тракта. Самара, 2002. 142 с.
4. Andre C., Kongier N., Schmidt D. et al. Langerhans cells: a key cell of sublingual specific immunotherapy // Eur. J. Allergy Clin. Immunol. 1997. Vol. 52. №37. P. 152-154.
5. Corren I. Allergic rhinitis and asthma: how important is the link? // J. Allergy Clin. Immunol. 1997. Vol. 99. №2. P 780-786.
6. Anolik R. // J. Asthma Allergy (ARIA). 2010. №3. P 87-99.
7. Bousquet J., Cauwenberge P Allergic rhinitis and its imact on asthma initiative // WHO initiative (ARIA). 2001. P 24.
8. Hindmarch I. Эффекты антигистаминных средств на ЦНС - существуют ли препараты третьего поколения. Тезисы 2-го интернационального симпозиума по лечению аллергии. Канны, 2000. С. 10-11.
9. Handley D., Magnetti A., Higgins A. Терапевтические преимущества антигистаминных препаратов третьего поколения // Exp. Opin. Invest. Drugs. 1998. №7(7). С. 1045-1054.
10. Berkowitz R.B., Roberson S. Onset of action of mometasone furoate nasal spray (MFNS) in seasonal allergic rhinitis // J. Allergy Clin. Immunol. 1998. №101: 244 (Abstract 1010).
11. Brannan M.D., Seiberling V., Cutler D.L et al. Lack of systemic activity with intranasal mometasone furoate // Ann. Allergy Asthma. Immunol. 1997. №97. P 198.
12. O' Brien F., Minshall E., Nolop K. et al. Histological and immunocytochemical assessment by nasal biopsy of mometasone furoate nasal spray in perennial rhinitis // Otolaryngol. Head. Neck. Surg. 1998. №118. P 648-654.
13. Hebert J.R., Nolop K., Lutsky B. Once daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: An active and placebo-controlled study // Allergy. 1996. №51.P. 569-576.
14. Minshall E., Ghaffar O., Cameron L. et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous spray (Nasonex) in the treatment of perennial rhinitis // Otolaryngol. Head. Neck. Surg. 1998. №118. P. 648-654.
Review
For citations:
Kryukov AI, Turovskiy AB, Bondareva GP, Semkina OV. Principles of allergic rhinitis treatment. Meditsinskiy sovet = Medical Council. 2013;(7):42-47. (In Russ.) https://doi.org/10.21518/2079-701X-2013-7-42-47
Views:
734
Email this article 